Table 1.
Total cohort of patients | Valid n | HCV (n = 275) | NAFLD (n = 212) | P-value |
---|---|---|---|---|
Agea | 487 | 58.6 (10.2) | 69.6 (8.7) | <0.001*a |
BMIa | 336 | 26.5 (5.2) | 32.3 (5.6) | <0.001*a |
Gender (Male) | 487 | 219 (79.6%) | 171 (80.7%) | 0.820 |
Ethnicity | 487 | <0.001* | ||
White | 198 (72.0%) | 208 (98.1%) | ||
Asian | 66 (24.0%) | 3 (1.4%) | ||
Black/Mixed | 11 (4.0%) | 1 (0.5%) | ||
DM (type 2) | 487 | 65 (23.6%) | 153 (72.2%) | <0.001* |
Alcohol Excess | 487 | 50 (18.2%) | 29 (13.7%) | 0.215 |
Cirrhotic | 487 | 271 (98.5%) | 185 (87.3%) | <0.001* |
MELDb | 287 | 9 (7 – 11) | 10 (8 – 13) | 0.142b |
Albumina | 288 | 37.2 (6.0) | 39.3 (5.6) | 0.006*a |
Transplanted cohort of patients | Valid n | HCV (n=80) | NAFLD (n=21) | P-value |
Agea | 101 | 54.0 (7.2) | 58.9 (5.5) | 0.005*a |
BMIa | 98 | 26.9 (4.5) | 32.1 (5.0) | <0.001*a |
Gender (Male) | 101 | 69 (86%) | 18 (86%) | 1.000 |
Ethnicity | 101 | 0.012* | ||
White | 58 (73%) | 21 (100%) | ||
Asian | 20 (25%) | 0 (0%) | ||
Black/Mixed | 2 (3%) | 0 (0%) | ||
DM (type 2) | 101 | 27 (34%) | 16 (76%) | <0.001* |
Alcohol Excess | 101 | 10 (13%) | 6 (29%) | 0.094 |
MELDb | 101 | 8 (7–11) | 10 (8–15) | 0.024*b |
Albumina | 101 | 37.9 (5.8) | 35.9 (7.3) | 0.177a |
Data reported as ‘n (%)’, with P-values from Fisher’s exact test, unless stated otherwise.
aData reported as ‘Mean (SD)’, with P-values from independent samples t-tests.
bData reported as ‘Median (Quartiles)’, with P-values from Mann–Whitney tests.
Significant at P < 0.05.